HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective effect of methyl lucidone against microglia-mediated neurotoxicity.

Abstract
Excessive microglial activation-mediated neurotoxicity has been implicated in playing a crucial role in the pathogenesis of stroke and neurodegenerative diseases. Therefore, much attention has been paid to therapeutic strategies aimed at suppressing neurotoxic microglial activation. The microglial regulatory mechanism of methyl lucidone, a cyclopentenedione isolated from the stem bark of Lindera erythrocarpa Makino, was investigated in the present study. Methyl lucidone treatment (0.1-10 μM) significantly inhibited lipopolysaccharide (LPS, 100 ng/ml, 24 h)-stimulated nitric oxide (NO) production in a dose-dependent manner in both primary cortical microglia and BV-2 cell line. Moreover, it strongly inhibited LPS-stimulated secretion of pro-inflammatory cytokines, such as interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α). Methyl lucidone treatment markedly induced down-regulation of LPS-induced nuclear translocation of nuclear factor κB (NF-κB) through preventing the degradation of the inhibitory protein IκBα. In addition, phosphorylation of Akt and mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK) and p38 kinases were also suppressed by methyl lucidone. The cell viabilities of HT-22 neurons were significantly attenuated by treatment of the conditioned media containing neurotoxic secretary molecules from LPS-stimulated microglia. However, methyl lucidone significantly blocked neuronal cell death induced by microglial conditioned media. These neuroprotective effects of methyl lucidone were also confirmed in a neuron-microglia co-culture system using EGFP-transfected B35 neuroblastoma cell line. Taken together, these results suggest that methyl lucidone may have a neuroprotective potential via inhibition of neurotoxic microglial activation implicated in neurodegeneration.
AuthorsYanji Cui, Jinji Wu, Sung-Cherl Jung, Gi-Ok Kim, Ryeo Kyeong Ko, Hye-Ja Lee, Eun-Sook Yoo, Hee-Kyoung Kang, Kyoungho Suk, Su-Yong Eun
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 690 Issue 1-3 Pg. 4-12 (Sep 05 2012) ISSN: 1879-0712 [Electronic] Netherlands
PMID22683871 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Culture Media, Conditioned
  • Cyclopentanes
  • Cytokines
  • Lipopolysaccharides
  • NF-kappa B
  • Neuroprotective Agents
  • methyllucidone
  • Nitric Oxide
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Cell Death (drug effects)
  • Cerebral Cortex (cytology)
  • Coculture Techniques
  • Culture Media, Conditioned (metabolism)
  • Cyclopentanes (pharmacology)
  • Cytokines (metabolism)
  • Lindera (chemistry)
  • Lipopolysaccharides (pharmacology)
  • Microglia (cytology, drug effects, metabolism)
  • Mitogen-Activated Protein Kinases (metabolism)
  • NF-kappa B (metabolism)
  • Neurons (cytology, drug effects, metabolism)
  • Neuroprotective Agents (pharmacology)
  • Nitric Oxide (biosynthesis)
  • Phosphorylation (drug effects)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: